Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
Recruiting
200 enrolled
ReAL
Recruiting
5,000 enrolled
EUREKA
Recruiting
400 enrolled
ProDigALIty
Recruiting
760 enrolled
Pre-malignant States to Hematologic Malignancies in Firefighters
Recruiting
300 enrolled
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
Recruiting
400 enrolled
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
Recruiting
1,000 enrolled
Collection of Tissue Samples for Cancer Research
Recruiting
5,000 enrolled
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Recruiting
500 enrolled
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Recruiting
2,000 enrolled
MoMMent
Recruiting
300 enrolled
REALiTEC/TAL
Recruiting
900 enrolled
Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma
Recruiting
70 enrolled
TRANSFORMM
Recruiting
1,000 enrolled
Tissue Collection for Studies of Lymph Cancer
Recruiting
1,295 enrolled
Study of CAR-T Therapy in Older Patients
Recruiting
154 enrolled
Predicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study
Recruiting
127 enrolled
Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma
Recruiting
50 enrolled
ITA-WebNet
Recruiting
1,000 enrolled
Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma
Recruiting
48 enrolled
B-SCR-MM
Recruiting
5,000 enrolled
Rapid dFLC Response Predict CHR in AL Amyloidosis
Recruiting
50 enrolled
GlycAL
Recruiting
100 enrolled
ALPS
Recruiting
100 enrolled
BE.Amycon Biobank & Data Registry UZ Leuven
Recruiting
505 enrolled
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Recruiting
25 enrolled
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
Recruiting
700 enrolled
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
Recruiting
75 enrolled
SPOTLIGHT
Recruiting
100 enrolled
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Recruiting
10,000 enrolled
NICHE
Recruiting
2,300 enrolled
DynaFiT
Recruiting
131 enrolled
GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma
Recruiting
210 enrolled
MYRIAM
Recruiting
2,200 enrolled
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Recruiting
500 enrolled
iCaRe2
Recruiting
999,999 enrolled
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Recruiting
50 enrolled
CAMPERR
Recruiting
7,000 enrolled
CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
Recruiting
1,665 enrolled
Institutional Registry of Rare Diseases
Recruiting
380 enrolled
GA-ACT
Recruiting
208 enrolled
CARE-Heme
Recruiting
5,000 enrolled
EMN36
Recruiting
6,000 enrolled
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Recruiting
10,000 enrolled
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
Recruiting
30,000 enrolled
LIBERATE
Recruiting
2,500 enrolled
Registry for Adults With Plasma Cell Disorders (PCD's)
Recruiting
2,000 enrolled
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
Recruiting
450 enrolled
MONOMM
Recruiting
25 enrolled
Long-term Follow-up Study of Patients Receiving CAR-T Cells
Recruiting
500 enrolled